Scientific articles 10 Oct 2026 Rethinking Clinical Trial Design to Accelerate Therapeutics for Arboviral Epidemics Open Forum Infectious Diseases
News 9 Oct 2026 DNDi 2026 Projects of the Year recognize teams and partners for their work to advance an open-science antiviral for future coronavirus pandemics and a single-dose treatment for sleeping sickness
Scientific articles 9 Oct 2026 A Perspective on Biomarkers, Candidates for Surrogate End Points to Accelerate Successful Development of New Antiparasitic Agents for the Treatment of Chronic Chagas Disease ACS Infectious Diseases
Press releases 6 Oct 2026 Ghana’s KNUST and DNDi partner to accelerate drug discovery for neglected diseases in Africa
Scientific articles 5 Oct 2026 Winning the endgame against sleeping sickness: Efficacy profiling of acoziborole against African trypanosomes with the focus on Trypanosoma brucei rhodesiense PLoS Neglected Tropical Diseases
Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
Scientific articles 22 Sep 2026 Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trial The Lancet Infection Diseases
Scientific articles 19 Sep 2026 Thermotherapy compared with intralesional sodium stibogluconate for Leishmania aethiopica cutaneous Leishmaniasis in Ethiopia: A phase II randomized controlled trial BMC Medicine
News 15 Sep 2026 New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D
In the media 9 Sep 2026 Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements Swissinfo
Scientific articles 1 Sep 2026 Analysis of the therapeutic gap for Trypanosoma cruzi infection in Colombia (2012 – 2022) Memórias do Instituto Oswaldo Cruz
Scientific articles 1 Jan 2022 The silent and dangerous inequity around access to COVID-19 testing: A call to action EClinicalMedicine
Scientific articles 31 Dec 2021 New chemotherapy regimens and biomarkers for Chagas disease: The rationale and design of the TESEO study, an open-label, randomised, prospective, phase-2 clinical trial in the Plurinational State of Bolivia BMJ Open
Scientific articles 24 Dec 2021 Assessing the impact of simplified HCV care on linkage to care amongst high-risk patients at primary healthcare clinics in Malaysia: a prospective observational study BMJ Open
Scientific articles 21 Dec 2021 Interruption of mother-to-child transmission and detection and treatment of children of infected mothers as a contribution to eradicate Chagas disease in Europe Real Academia Nacional de Medicina
Scientific articles 3 Dec 2021 Target 2035 – update on the quest for a probe for every protein RSC Medicinal Chemistry
Scientific articles 2 Dec 2021 Pharmacokinetics and safety of the abacavir/ lamivudine/ lopinavir/ ritonavir fixed-dose granule formulation (4-in-1) in neonates Journal of Acquired Immune Deficiency Syndromes
Scientific articles 18 Nov 2021 Geographic variations in test reactivity for the serological diagnosis of Trypanosoma cruzi infection Journal of Clinical Microbiology
Scientific articles 17 Nov 2021 Towards the elimination of visceral leishmaniasis as a public health problem in East Africa: reflections on an enhanced control strategy and a call for action The Lancet Global Health
Scientific articles 8 Nov 2021 Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: Report from a field study PLOS Neglected Tropical Diseases
Scientific articles 29 Oct 2021 On-site experience of a project to increase access to diagnosis and treatment of Chagas disease in high-risk endemic areas of Colombia Acta Tropica
Scientific articles 28 Oct 2021 Chagas disease drug discovery in Latin America – A mini review of antiparasitic agents explored between 2010 and 2021 Frontiers in Chemistry
Scientific articles 28 Oct 2021 DNDI-6148: A novel benzoxaborole preclinical candidate for the treatment of visceral leishmaniasis Journal of Medicinal Chemistry
Scientific articles 25 Oct 2021 Snakebites and COVID-19: two crises, one research and development opportunity BMJ Global Health
Scientific articles 20 Oct 2021 Ravidasvir: equitable access through an alternative drug development pathway The Lancet Global Health
Scientific articles 14 Oct 2021 A multidisciplinary, collaborative, inter-agency and comprehensive approach for the control of Chagas disease as a public health problem in Guatemala Acta Tropica